Related Experiment Video
Updated: Jan 28, 2026

Evaluation of Respiratory System Mechanics in Mice using the Forced Oscillation Technique
Published on: May 15, 2013
Airway hyperresponsiveness in young children with respiratory symptoms: A five-year follow-up
Satu Kalliola1, L Pekka Malmberg2, Kristiina Malmström2
1Helsinki University Hospital, Children and Adolescents, Lohja Hospital, Finland.
Insights
Airway hyperresponsiveness (AHR) in wheezy infants predicts later asthma and exercise-induced bronchoconstriction. Early AHR suggests a persistent condition, not transient wheezing, in children.
Area of Science:
- Pediatric Pulmonology
- Allergy and Immunology
- Respiratory Medicine
Background:
- Recurrent wheezing in infancy is often transient.
- The role of airway hyperresponsiveness (AHR) in persistent respiratory symptoms is debated.
Purpose of the Study:
- To determine if AHR in wheezy infants predicts doctor-diagnosed asthma (DDA) or AHR at age 6.
- To investigate the long-term respiratory outcomes in infants with early wheezing and AHR.
Main Methods:
- Followed 61 wheezy infants (6-24 months) to age 6.
- Assessed lung function and AHR via methacholine challenge in infancy and at 6 years.
- Used exercise challenge tests and skin prick tests for atopy at age 6.
Main Results:
- 34% of children had DDA at age 6.
- Infants with DDA showed higher methacholine reactivity (LOGDRS).
- AHR in infancy correlated with AHR at age 6; early AHR predicted exercise-induced bronchoconstriction.
Conclusions:
- Increased AHR in symptomatic infants is linked to persistent AHR, DDA, and exercise-induced bronchoconstriction at age 6.
- Findings suggest early AHR is established early in life.
- Early identification of AHR may aid in predicting long-term respiratory health.
Background:
Recurrent wheezing in early life is transient in most children. The significance of airway hyperresponsiveness (AHR) in persistence of respiratory symptoms from infancy to early childhood is controversial.
Objective:
We evaluated whether AHR in wheezy infants predicts doctor-diagnosed asthma (DDA) or AHR at the age of 6 years.
Methods:
Sixty-one wheezy infants (age 6-24 months) were followed up to the median age of 6 years. Lung function and AHR with methacholine challenge test were assessed at infancy and 6 years. The exercise challenge test was performed at the age of 6 years. Atopy was assessed with skin prick tests.
Results:
At 6 years, 21 (34%) of the children had DDA. Children with DDA had higher logarithmic transformed dose-response slope (LOGDRS) to methacholine in infancy than children without DDA (0.047 vs 0.025; P = .033). Furthermore, AHR to methacholine in infancy and at 6 years were associated with each other (r = 0.324, P = .011). Children with exercise-induced bronchoconstriction (EIB) at 6 years were more reactive to methacholine in infancy than those without EIB (P = .019).
Conclusion:
Increased AHR in symptomatic infants was associated with increased AHR, DDA, and EIB at median the age of 6 years, suggesting early establishment of AHR.
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Anatomy of Respiratory System II: Lower Respiratory Tract
The Larynx
It is located between the pharynx and the trachea, acts as a passageway for air, and hosts several critical structures, such as the epiglottis, vocal cords, and glottis. The epiglottis acts as a gateway, guiding food to the...
The Respiratory System
Asthma-III: Symptoms and Complications
Classification of Asthma
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:

